GE Healthcare is the result of the merger between GE Medical and Amersham Health in Nov. 2004, after GE acquired Amersham Health for 9.5 billion in Oct. 2003. Jeffrey R. Immelt, Chairman of the Board and Chief Executive of General Electric, said, 'Amersham's diagnostic pharmaceutical and life sciences business will add new, high growth platforms to GE Medical's diagnostic imaging, services and healthcare information technology businesses'. GE Healthcare, a UK company, is a unit of General Electric (NYSE: GE). GE Healthcare is a global leader in medical imaging, diagnostic imaging contrast agents, interventional procedures, healthcare services, and information technology. For more than 100 years, health care providers have relied on GE Medical Systems, now GE Healthcare, for high quality medical technology and productivity solutions. GE Healthcare, headquartered now at formerly seat of Amersham Health in Great Britain, operates facilities around the world. Global Operations include organizations on the Americas, Europe, and Asia, including India, Japan, Korea China, Thailand and Vietnam.

MRI Scanners:

0.2T to 1.0T:
to 1.5T:
to 3.0T:

MRI Contrast Agents:

[This entry is marked for removal.]

GE Medical Systems and Amersham announced in April 2004 the completion of a share exchange acquisition of Amersham Health by GE. The result of this acquisition is the new GE Healthcare, based in the UK, totally owned by General Electric (GE).

Amersham Health, was the imaging diagnostics and therapy business of Amersham plc.

The rapid improvements in instrumentation, which have added benefit to the use of extracellular fluid agents such as Omniscan™, have also diminished the market potential for blood pool products such as Clariscan™. As a consequence, Amersham decided to discontinue the development of Clariscan™.

[This entry is marked for removal.]

GE Medical Systems and Amersham announced in April 2004 the completion of a share exchange acquisition of Amersham Health by GE. The result of this acquisition is the new GE Healthcare, based in the UK, totally owned by General Electric (GE).

Amersham plc, was a producer of contrast imaging agents used to enhance image quality in X-ray, magnetic resonance imaging, and ultrasound procedures. It was also a leading producer of radiopharmaceuticals used in nuclear medicine imaging. Amersham Health was the firm's imaging, diagnostics, and therapeutics segment. Amersham plc was involved in biotechnology research through its Amersham Biosciences unit, which made scanners, sequencers, microarrays, industrial separations, and other research supplies.

[This entry is marked for removal.]

General Electric (GE) agreed to buy diagnostic systems maker Lunar Corp. for $150m. in March 2000. In 2004/05 it seems that the integration process into GE Healthcare has been completed. (GE Medical Systems and Amersham announced in April 2004 the completion of a share exchange acquisition of Amersham Health by GE. The result of this acquisition is the new GE Healthcare, based in the UK, totally owned by General Electric (GE).

The U.S.-based company developed bone densitometers and scanning machines that measure bone density as a way of diagnosing osteoporosis and other metabolic bone diseases. GE Lunar marketed these products worldwide.
GE Lunar announced a distribution agreement with MagneVu for domestic sales of the MagneVu 1000, a portable MRI device for orthopedic use, under the trade name Applause™.
GE Lunar was the exclusive U.S. distributor of MR-devices manufactured by Esaote S.p.A. These compact in-office MRI™ machines are designed to fit all practice sizes in orthopedic imaging and complete the range of diagnostic imaging systems.

From Hitachi Medical Systems America, Inc.;
the AIRIS made its debut in 1995. Hitachi followed up with the AIRIS II system, which has proven equally successfully. 'All told, Hitachi has installed more than 1,000 MRI systems in the U.S., holding more than 17 percent of the total U.S. MRI installed base, and more than half of the installed base of open MR systems,' says Antonio Garcia, Frost and Sullivan industry research analyst. Now Altaire employs a blend of innovative Hitachi features called VOSI™ technology, optimizing each sub-system's performance in concert with the other sub-systems, to give the seamless mix of high-field performance and the patient comfort, especially for claustrophobic patients, of open MR systems.